scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1002464664 |
P356 | DOI | 10.1007/S11892-016-0720-Z |
P698 | PubMed publication ID | 26971119 |
P2093 | author name string | Guillermo Umpierrez | |
Arnold J Berry | |||
Elizabeth W Duggan | |||
Matthew A Klopman | |||
P2860 | cites work | Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline | Q57245230 |
Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk | Q57412871 | ||
Clinical features of hyperosmolar hyperglycemic nonketotic diabetic coma associated with cardiac operations | Q68879521 | ||
Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence | Q69600813 | ||
Impaired leucocyte functions in diabetic patients | Q73032290 | ||
Nonspecific immunity in diabetes: hyperglycemia decreases phagocytic activity of leukocytes in diabetic patients | Q73643498 | ||
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial) | Q80358416 | ||
Overt diabetes mellitus adversely affects surgical outcomes of noncardiovascular patients | Q82382001 | ||
Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol | Q82789497 | ||
Patient guide to managing hyperglycemia (high blood sugar) in the hospital | Q83187639 | ||
Hypoglycemia in hospitalized patients treated with sulfonylureas | Q84091503 | ||
Root causes of intraoperative hypoglycemia: a case series | Q85332227 | ||
Intensive insulin therapy in critically ill patients | Q29618795 | ||
Stress-induced hyperglycemia | Q32060199 | ||
The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery | Q33401996 | ||
Elevated plasma free fatty acids are associated with sudden death: a prospective community-based evaluation at the time of cardiac arrest | Q33835566 | ||
Hypoglycemia, diabetes, and cardiovascular events | Q33873251 | ||
Inpatient management of type 2 Diabetes Mellitus: Does choice of insulin regimen really matter? | Q34002051 | ||
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis | Q34002421 | ||
Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery | Q34016041 | ||
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress | Q34154404 | ||
Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program | Q34399092 | ||
Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes | Q34401483 | ||
Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation | Q34454077 | ||
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery) | Q34507005 | ||
Adverse drug events occurring following hospital discharge | Q34722873 | ||
Sliding scale insulin--time to stop sliding | Q34921052 | ||
Tumor necrosis factor alpha inhibits signaling from the insulin receptor | Q35304189 | ||
Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes | Q35561368 | ||
Management of diabetes and hyperglycemia in hospitals | Q35640694 | ||
Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control | Q35651338 | ||
Insulin pump patient characteristics and glucose control in the hospitalized setting | Q35682820 | ||
Anesthesia Preoperative Clinic Referral for Elevated Hba1c Reduces Complication Rate in Diabetic Patients Undergoing Total Joint Arthroplasty | Q35825044 | ||
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients | Q35912987 | ||
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial | Q35973242 | ||
Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects | Q36186280 | ||
Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. | Q36439470 | ||
Perioperative glucose control in the diabetic or nondiabetic patient | Q36519310 | ||
Oxidative stress, insulin signaling, and diabetes. | Q36570342 | ||
Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes | Q36605674 | ||
Clinical practice. Management of hyperglycemia in the hospital setting | Q36641921 | ||
Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy | Q36710637 | ||
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. | Q37022653 | ||
Glycemic control in non-diabetic critically ill patients | Q37032717 | ||
A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms | Q37070157 | ||
Insulin therapy for the management of hyperglycemia in hospitalized patients | Q37082032 | ||
Medical nutrition therapy in hospitalized patients with diabetes | Q37102807 | ||
Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes | Q37106574 | ||
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control | Q37189275 | ||
Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial | Q37235879 | ||
Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward | Q37235921 | ||
Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study | Q37278202 | ||
Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts | Q37308268 | ||
Perioperative glycemic control: an evidence-based review | Q37385730 | ||
Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients | Q37391059 | ||
Plasma fatty acid composition and incident ischemic stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study | Q37419141 | ||
Inpatient to outpatient transfer of diabetes care: planing for an effective hospital discharge | Q37443396 | ||
Stress hyperglycaemia | Q37493834 | ||
Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery | Q37796493 | ||
Management of hyperglycemia during the perioperative period | Q37956543 | ||
Perioperative glycemic control | Q38044530 | ||
Impact of hypoglycemia in hospitalized patients | Q38052075 | ||
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients | Q38060936 | ||
Management of the hospitalized patient with type 1 diabetes mellitus | Q38129190 | ||
Approach to the adult hospitalized patient on an insulin pump | Q38162423 | ||
Glycaemic control in the perioperative period | Q38171041 | ||
Management of patients with type 1 diabetes in the hospital | Q38176514 | ||
Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery | Q38464593 | ||
NHS Diabetes guideline for the perioperative management of the adult patient with diabetes | Q38567730 | ||
Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia | Q39428459 | ||
Effects of glucocorticoids on carbohydrate metabolism | Q39631347 | ||
Inpatient glucose control: a glycemic survey of 126 U.S. hospitals | Q39912110 | ||
Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias | Q40619598 | ||
TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells | Q40954084 | ||
The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients | Q41381489 | ||
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output | Q42467904 | ||
Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients | Q43134075 | ||
Predictive Value of Admission Hemoglobin A1c on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes | Q43158344 | ||
Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. | Q43256893 | ||
Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction | Q43618967 | ||
Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. | Q43633897 | ||
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises | Q43637162 | ||
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes | Q43913786 | ||
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. | Q43935446 | ||
Preoperative blood glucose concentrations and postoperative outcomes after elective non-cardiac surgery: an observational study | Q44030355 | ||
Early postoperative glucose control predicts nosocomial infection rate in diabetic patients | Q44067972 | ||
Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. | Q44275280 | ||
Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting | Q44456854 | ||
Experience with the continuous glucose monitoring system in a medical intensive care unit | Q44937941 | ||
Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission | Q45335541 | ||
Elevated admission glucose and mortality in elderly patients hospitalized with heart failure | Q45352998 | ||
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. | Q46005098 | ||
Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery | Q46214290 | ||
Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery | Q46218908 | ||
Evidence for strict inpatient blood glucose control: time to revise glycemic goals in hospitalized patients | Q46851297 | ||
Hypoglycemia and risk of death in critically ill patients | Q46875254 | ||
Early Identification of Individuals with Poorly Controlled Diabetes Undergoing Elective Surgery: Improving A1C Testing in the Preoperative Period | Q47793441 | ||
Hyperglycemia or high hemoglobin A1C: Which one is more associated with morbidity and mortality after coronary artery bypass graft surgery? | Q48009163 | ||
Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients | Q48236291 | ||
BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA. | Q50541644 | ||
Implementing an intravenous insulin infusion protocol in the intensive care unit. | Q50909902 | ||
Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. | Q50982387 | ||
Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcome measures. | Q51321196 | ||
Insulin glargine dosing before next-day surgery: comparing three strategies. | Q51349497 | ||
The permissive effects of glucocorticoid on hepatic gluconeogenesis. Glucagon stimulation of glucose-suppressed gluconeogenesis and inhibition of 6-phosphofructo-1-kinase in hepatocytes from fasted rats | Q51642281 | ||
Inpatient management of hyperglycemia: the Northwestern experience. | Q51932699 | ||
Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. | Q54195074 | ||
Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. | Q54581737 | ||
P433 | issue | 3 | |
P921 | main subject | cardiac surgery | Q235007 |
hyperglycemia | Q271993 | ||
P304 | page(s) | 34 | |
P577 | publication date | 2016-03-01 | |
P1433 | published in | Current diabetes report | Q26841965 |
P1476 | title | The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients | |
P478 | volume | 16 |
Q40476591 | Inflammation and Oxidative Stress in Cardiac Surgery Patients Treated to Intensive Versus Conservative Glucose Targets. |
Q40469517 | Inpatient glycemic management in internal medicine: an observational multicenter study in Nanjing, China. |
Q53753874 | Perioperative Hyperglycemia Management: An Update. |
Search more.